Market Place
Upload your Marketing & Sales content on your company Virtual Booth, click HERE
X
Please Wait
Applying Filters...
01 Catalent Micron Technologies, Inc. (1)
02 Lonza AG (2)
01 Vandetanib (1)
02 vandetanib (1)
03 vandetanib non-mc (1)
01 U.S.A (3)
37
PharmaCompass offers a list of VANDETANIB API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right VANDETANIB manufacturer or VANDETANIB supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred VANDETANIB manufacturer or VANDETANIB supplier.
PharmaCompass also assists you with knowing the VANDETANIB API Price utilized in the formulation of products. VANDETANIB API Price is not always fixed or binding as the VANDETANIB Price is obtained through a variety of data sources. The VANDETANIB Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Caprelsa manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Caprelsa, including repackagers and relabelers. The FDA regulates Caprelsa manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Caprelsa API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Caprelsa manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Caprelsa supplier is an individual or a company that provides Caprelsa active pharmaceutical ingredient (API) or Caprelsa finished formulations upon request. The Caprelsa suppliers may include Caprelsa API manufacturers, exporters, distributors and traders.
click here to find a list of Caprelsa suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Caprelsa as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Caprelsa API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Caprelsa as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Caprelsa and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Caprelsa NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Caprelsa suppliers with NDC on PharmaCompass.
We have 2 companies offering Caprelsa
Get in contact with the supplier of your choice:
